PEPCID AC Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Pepcid Ac patents expire, and what generic alternatives are available?
Pepcid Ac is a drug marketed by J And J Consumer Inc and is included in three NDAs. There is one patent protecting this drug.
The generic ingredient in PEPCID AC is famotidine. There are eighteen drug master file entries for this compound. One hundred and eighteen suppliers are listed for this compound. Additional details are available on the famotidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pepcid Ac
A generic version of PEPCID AC was approved as famotidine by ATHENEX INC on April 16th, 2001.
Summary for PEPCID AC
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 34 |
Patent Applications: | 5,523 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in PEPCID AC? | PEPCID AC excipients list |
DailyMed Link: | PEPCID AC at DailyMed |

Recent Clinical Trials for PEPCID AC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ohio State University Comprehensive Cancer Center | Phase 2/Phase 3 |
Leidos Life Sciences | Phase 2 |
United States Department of Defense | Phase 2 |
Pharmacology for PEPCID AC
Drug Class | Histamine-2 Receptor Antagonist |
Mechanism of Action | Histamine H2 Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for PEPCID AC
US Patents and Regulatory Information for PEPCID AC
PEPCID AC is protected by one US patents.
Patents protecting PEPCID AC
Process for preparing a soft tablet
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J And J Consumer Inc | PEPCID AC | famotidine | TABLET, CHEWABLE;ORAL | 020801-001 | Sep 24, 1998 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
J And J Consumer Inc | PEPCID AC | famotidine | TABLET, CHEWABLE;ORAL | 020801-002 | Dec 17, 2007 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020325-001 | Apr 28, 1995 | OTC | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020325-002 | Sep 23, 2003 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PEPCID AC
International Patents for PEPCID AC
See the table below for patents covering PEPCID AC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0279682 | GELATIN COATED CAPLETS AND PROCESS FOR MAKING SAME | ⤷ Try a Trial |
Greece | 920100438 | ⤷ Try a Trial | |
Japan | S6256871 | ⤷ Try a Trial | |
Switzerland | 648027 | GUANIDINOTHIAZOLVERBINDUNGEN, VERFAHREN ZU DEREN HERSTELLUNG UND ARZNEIMITTELZUBEREITUNGEN. | ⤷ Try a Trial |
Japan | H06316536 | TASTE-MASKING AND SUSTAINED-RELEASE FILM FOR MEDICINE | ⤷ Try a Trial |
South Africa | 8000970 | ⤷ Try a Trial | |
Philippines | 26756 | Method for double dipping gelatin coated caplets | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |